The FDA has approved palbociclib (Ibrance) in combination with trastuzumab (Herceptin), endocrine therapy, and optionally pertuzumab (Perjeta) as a maintenance treatment for adults with HR+/HER2+ ...

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, offering a more precise first‑line.

Your health needs change as you age. Treatment for common types of breast cancer in older adults may change, too. Learning you have breast cancer is stressful at any age. But you may learn you have ...